Skip to main content
AMP 2024 Annual Meeting & Expo Main banner
Final Program


Icon Legend

  1. Home

  • Thursday, Nov 21st
    10:15 AM – 11:45 AM PST
    Strategies and Challenges of Measurable Residual Disease Testing in Acute Myeloid Leukemia
    Location: 109 & 110, Level 1
    Program Committee Moderator: Amir Behdad, MD, MBA (he/him/his) – Cleveland Clinic Florida
    Co-Moderator (Early Career): Bing Melody Zhang, MD (she/her/hers) – Stanford University School of Medicine
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    10:15 AM – 11:00 AM PST
    Quantification of Measurable Residual Disease in Adults with Acute Myeloid Leukemia
    Location: 109 & 110, Level 1
    Breakout Speaker: Christopher S. Hourigan, DM DPhil (he/him/his) – Virginia Tech FBRI Cancer Research Center
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    11:00 AM – 11:45 AM PST
    AML MRD Analysis Using FLT3-ITD
    Location: 109 & 110, Level 1
    Breakout Speaker: Mark Levis, MD PhD – Johns Hopkins
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    2:30 PM – 3:30 PM PST
    AMP/CAP/NSGC Slice Testing—Considerations from Ordering to Reporting
    Location: 301 - 305, Level 3
    Working Group Moderator: Susan Hsiao, MD, PhD – Columbia University Irving Medical Center
    Inherited Conditions
  • Thursday, Nov 21st
    2:30 PM – 3:30 PM PST
    AMP/CAP/NSGC Slice Testing—Considerations from Ordering to Reporting
    Location: 301 - 305, Level 3
    Working Group Speaker: Jeffrey SoRelle, MD – UT Southwestern
    Panelist: Rong Mao, MD (she/her/hers) – University of Utah/ARUP Laboratories
    Panelist: Birgit Funke, PhD (she/her/hers) – Shriners Children’s Genomics Institute
    Inherited Conditions
  • Friday, Nov 22nd
    10:15 AM – 11:45 AM PST
    A RefResher in Laboratory Statistics: Using R in Validations and Verifications
    Location: Ballroom, Level 1
    Program Committee Moderator: Tessara Baldi (she/her/hers) – Memorial Sloan Kettering Cancer Center
    Co-Moderator (Early Career): Michael O. Alberti, MD, PhD (he/him/his) – University of Colorado Anschutz Medical Campus
    Lab Management
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 11:45 AM PST
    Molecular at Home and Point of Care Testing for Infectious Diseases
    Location: 301 - 305, Level 3
    Program Committee Moderator: Heba Mostafa, MD. PhD. D(ABMM) (she/her/hers) – Johns Hopkins Medical Institutions
    Co-Moderator (Early Career): Yi Ding, MD, PhD – Geisinger Medical Center
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Friday, Nov 22nd
    10:15 AM – 11:45 AM PST
    Utilization of Cell Free DNA in Characterization and Detection of Minimal Residual Disease in Lymphoid Malignancies
    Location: 118 - 120, Level 1
    Program Committee Moderator: Craig Soderquist, MD – Columbia University
    Co-Moderator (Early Career): Zejuan Li, MD, PhD, FACMG – Houston Methodist Hospital
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 10:45 AM PST
    Cost-Effectiveness, Economic, and Business Considerations for Point-ofCare, At Home, and Home Collection Testing
    Location: 301 - 305, Level 3
    Breakout Speaker: Kevin D. Frick, PhD (they/them/theirs) – Johns Hopkins Carey Business School
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Friday, Nov 22nd
    10:15 AM – 11:00 AM PST
    A RefResher in Laboratory Statistics: Using R in Validations and Verifications
    Location: Ballroom, Level 1
    Breakout Speaker: Amir Momeni, MD (he/him/his) – Memorial Sloan Kettering Cancer Center
    Lab Management
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 11:00 AM PST
    cfDNA in Early Detection of Hematologic malignancies
    Location: 118 - 120, Level 1
    Breakout Speaker: Rita Shaknovich, MD, PhD – Shaknovich Consulting LLC
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:45 AM – 11:15 AM PST
    Integrating At-Home and Point-of-Care Testing into Clinical Care: Impacts on Physician Decision-Making in Real-World Settings
    Location: 301 - 305, Level 3
    Breakout Speaker: Jeremiah Hinson, MD, PhD (he/him/his) – Johns Hopkins Medicine
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Friday, Nov 22nd
    11:00 AM – 11:45 AM PST
    A RefResher in Laboratory Statistics: Using R in Validations and Verifications
    Location: Ballroom, Level 1
    Breakout Speaker: Amrom Obstfeld, MD PhD – University of Pennsylvania Perelman School of Medicine
    Lab Management
     CE Credit: 1.5
  • Friday, Nov 22nd
    11:00 AM – 11:45 AM PST
    Profiling Cell-Free DNA in Lymphoma: MRD and Beyond
    Location: 118 - 120, Level 1
    Breakout Speaker: Brian Sworder, MD, PhD (he/him/his) – University of California, Irvine
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    11:15 AM – 11:45 AM PST
    FDA Perspectives on Molecular at Home and Point of Care Testing for Infectious Diseases
    Location: 301 - 305, Level 3
    Breakout Speaker: Courtney H. Lias, PhD (she/her/hers) – FDA
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Friday, Nov 22nd
    1:15 PM – 2:45 PM PST
    Whole Exome Sequencing in Solid Tumors - the Changing Paradigm of Clinical Oncology
    Location: 220 - 222, Level 2
    Program Committee Moderator: Deepika Sirohi, MD – University of California San Francisco
    Co-Moderator (Early Career): John M. Skaugen, MD (he/him/his) – University of Pittsburgh School of Medicine
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    1:15 PM – 2:00 PM PST
    Clinical Cancer Whole Exome and Transcriptome Sequencing: Lessons learned over 10 years and future outlook
    Location: 220 - 222, Level 2
    Breakout Speaker: Susan Hsiao, MD, PhD – Columbia University Irving Medical Center
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    2:00 PM – 2:45 PM PST
    Clinical Validation and Implementation of Somatic Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) for Solid Tumors and Hematopoietic Neoplasms.
    Location: 220 - 222, Level 2
    Breakout Speaker: Laura Tafe, MD (she/her/hers) – Dartmouth-Hitchcock Medical Center
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    3:45 PM – 4:45 PM PST
    Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
    Location: Ballroom, Level 1
    Program Committee Moderator: Arivarasan Karunamurthy, MD (he/him/his) – University of Pittsburgh Medical Center
    Program Committee Moderator: Deepika Sirohi, MD – University of California San Francisco
    Oncology
     CE Credit: 1.0
  • Friday, Nov 22nd
    3:45 PM – 4:45 PM PST
    Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
    Location: Ballroom, Level 1
    Plenary Speaker: Peter K. Sorger, PhD (he/him/his) – Harvard Medical School
    Oncology
     CE Credit: 1.0
  • Saturday, Nov 23rd
    10:15 AM – 11:45 AM PST
    Advances in Characterizing Structural Chromosomal Alterations: Utility of Optical Genome Mapping and Long Read Sequencing in Hematopoietic Cancers and the Germline Genome
    Location: 109 & 110, Level 1
    Program Committee Moderator: Craig Soderquist, MD – Columbia University
    Program Committee Moderator: Honey Reddi, PhD, FACMG (she/her/hers) – Belay Diagnostics
    Co-Moderator (Early Career): Eric McGinnis, MD (he/him/his) – Vancouver General Hospital / University of British Columbia
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:15 AM – 11:45 AM PST
    Syndromic Panels for Infectious Disease Diagnosis
    Location: 211 - 214, Level 2
    Program Committee Moderator: Heba Mostafa, MD. PhD. D(ABMM) (she/her/hers) – Johns Hopkins Medical Institutions
    Co-Moderator (Early Career): Kenneth Gavina, PhD, D(ABMM) (he/him/his) – Indiana University School of Medicine
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    10:15 AM – 10:45 AM PST
    Multiplex Syndromic Panels: Challenges and Opportunities for Reimbursement
    Location: 211 - 214, Level 2
    Breakout Speaker: Meghan Starolis, PhD – Quest Diagnostics
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    10:15 AM – 11:00 AM PST
    Optical Genome Mapping - A New Age in Cytogenetics
    Location: 109 & 110, Level 1
    Breakout Speaker: Brynn Levy, MSc(Med), PhD (he/him/his) – Columbia University
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:45 AM – 11:15 AM PST
    Multiplex Infectious Disease Molecular Panels: Technology and Challenges
    Location: 211 - 214, Level 2
    Breakout Speaker: Linoj Samuel, PhD – Henry Ford Health
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    11:00 AM – 11:45 AM PST
    Long Read Sequencing: The Long and Short of It.
    Location: 109 & 110, Level 1
    Breakout Speaker: Fritz Sedlazeck, Baylor College of Medicine – Baylor College of Medicine
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    11:15 AM – 11:45 AM PST
    Unraveling Complexity: the Clinical Benefits and Challenges of Syndromic Panel Testing
    Location: 211 - 214, Level 2
    Breakout Speaker: Bert K. Lopansri, MD (he/him/his) – Intermountain Medical Center
    Infectious Diseases
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    1:15 PM – 2:15 PM PST
    2024 CAP/IASLC/AMP Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline Update
    Location: 301 - 305, Level 3
    Working Group Moderator: Susan Hsiao, MD, PhD – Columbia University Irving Medical Center
    Oncology
  • Saturday, Nov 23rd
    1:15 PM – 2:15 PM PST
    2024 CAP/IASLC/AMP Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline Update
    Location: 301 - 305, Level 3
    Working Group Speaker: Dhananjay A. Chitale, MD, MBA (he/him/his) – Henry Ford Health
    Oncology
  • Saturday, Nov 23rd
    2:30 PM – 4:00 PM PST
    From Pathology to the Biobank: Considerations for Managing Laboratory Samples and Data
    Location: 301 - 305, Level 3
    Program Committee Moderator: Tessara Baldi (she/her/hers) – Memorial Sloan Kettering Cancer Center
    Co-Moderator (Early Career): Lulu Sun, MD, PhD (she/her/hers) – Washington University in St. Louis School of Medicine
    Lab Management
     CE Credit: 1.5
  • Saturday, Nov 23rd
    2:30 PM – 4:00 PM PST
    Role of Gender Identification in Genetic Testing
    Location: 109 & 110, Level 1
    Program Committee Moderator: Stuart A. Scott, PhD – Stanford
    Co-Moderator (Early Career): Stephanie Siegmund, MD PhD (she/her/hers) – Harvard Medical School / Brigham & Women's Hospital
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    2:30 PM – 3:00 PM PST
    Sex and Gender in Medicine: The Basics
    Location: 109 & 110, Level 1
    Breakout Speaker: J9 Austin, PhD, CGC, FCAHS (they/them/theirs) – Departments of Psychiatry and Medical Genetics, University of British Columbia
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    2:30 PM – 3:15 PM PST
    Supporting Research Biobanking in the Pathology Lab
    Location: 301 - 305, Level 3
    Lab Management
     CE Credit: 1.5
  • Saturday, Nov 23rd
    3:00 PM – 3:30 PM PST
    Role of Sex and Gender in Clinical Oncology and Medical Genetics
    Location: 109 & 110, Level 1
    Breakout Speaker: Gwendolyn Quinn, PhD (she/her/hers) – , NYU Grossman School of Medicine, New York City, NY, USA
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: 1.5
  • Saturday, Nov 23rd
    3:15 PM – 4:00 PM PST
    Pathology, Sample Collection and the Biobanking Continuum in Healthcare Research
    Location: 301 - 305, Level 3
    Breakout Speaker: Marianne K. Henderson, MS, PMP (she/her/hers) – DCEG/NCI/NIH
    Lab Management
     CE Credit: 1.5
  • Saturday, Nov 23rd
    3:30 PM – 4:00 PM PST
    How Labs Can Be Allies: Why Language Matters for Testing Accuracy and Patient Experience
    Location: 109 & 110, Level 1
    Breakout Speaker: Margo Gallegos, MS, LCGC (she/her/hers) – Ambry Genetics
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: NOT CME/CMLE